Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

E pili ana i kā mākou huiʻIkepili Lapaʻau CAR-T

ʻO ka CAR-T Therapy, pōkole no Chimeric Antigen Receptor T-Cell Immunotherapy, he ʻano hana lapaʻau gene holomua e pili ana i ka hoʻololi ʻana i nā pūnaewele T ponoʻī o ka mea maʻi e kuhikuhi a luku i nā pūnaewele kanesa. ʻAʻole e like me nā lāʻau lapaʻau kuʻuna, ua hana kūikawā ʻia ka CAR-T therapy no kēlā me kēia mea maʻi a koi ʻia ka hōʻiliʻili ʻana i nā pūnaewele T mai ke koko o ka mea maʻi ma mua o ka hoʻihoʻi ʻana iā lākou i loko o ke kino ma hope o ka ʻenekinia genetic.
KA NĀNĀWAI HOʻOMAʻAMAʻA CAR-T (1)smn
E ʻimi i nā hiʻohiʻona

Nā hōʻailona o CAR-T

● Leukemia lymphoblastic koʻikoʻi o nā cell B

● Myeloma lehulehu

● Leukemia lymphocytic mau loa

● Lymphoma ʻaʻole Hodgkin

● Lymphoma cell B nui e pālahalaha ana

● SLE(Lupus Erythematosus ʻōnaehana)

Hana maikaʻi loa o ka hana lapaʻau CAR-T

Nā hōʻailona no CD19+20CAR-T: Nā maʻi me ka lymphoma B-cell non Hodgkin

Ka uku CR hoʻokahi mahina

Ka uku PR hoʻokahi mahina

Hoʻokahi mahina OR uku

CRS≥3

CRES≥3

71.95%(59/82)

25.6(21/82)

97.55(80/82)

12.19%(10/82)

0

Nā hōʻailona no CD19+22CAR-T: Ka mālama ʻana i nā maʻi leukemia B-lymphocytic acute i hoʻihoʻi ʻia mai ka CD19 a me ka refractory

Ka uku CR hoʻokahi mahina

Ka uku PR hoʻokahi mahina

Hoʻokahi mahina OR uku

CRS≥3

CRES≥3

92.1%(35/38)

7.9%(3/38)

100%(38/38)

15.79%(6/38)

0

Nā hōʻailona no BCMACAR-T: Ka mālama ʻana i ka myeloma maha relapsed a me ka refractory

Ka uku CR hoʻokahi mahina

Ka uku PR hoʻokahi mahina

Hoʻokahi mahina OR uku

CRS≥3

CRES≥3

72.41%(21/29)

27.59%(8/29)

100%(29/29)

6.9%(2/29)

0

NĀNĀ HOU NO KA CAR-T THERAPY (2)6u3

No ke aha e koho ai iā mākou?

Ko mākou mau pono

Lapaʻau Pilikino: Hoʻopilikino mākou i ka lāʻau lapaʻau CAR-T no kēlā me kēia maʻi, e hōʻoiaʻiʻo ana i ka lāʻau lapaʻau i kuhikuhi ʻia a kūpono hoʻi.

Nā Koho Hoʻolālā Like ʻOle: Hāʻawi kā mākou huahana CAR-T i kahi ākea o nā koho hoʻolālā, me CD7, CD19, CD20, CD22, a me BCMA, e hāʻawi ana i ka pono o nā koho lapaʻau pilikino no nā mea maʻi.

ʻEnehana ʻoi loa: Hoʻohana kā mākou lāʻau lapaʻau CAR-T i nā holomua hou loa i ka ʻenekinia genetic a me ka immunotherapy.

Ka uku kūpono kiʻekiʻe: Ke hoʻohālikelike ʻia me nā huahana ʻē aʻe, hāʻawi mākou i kahi kaulike kiʻekiʻe ma waena o ka hōʻoia maikaʻi a me ke kumukūʻai hoʻokūkū.

ʻIke Lapaʻau: Kākoʻo ʻia e kahi hui o nā kauka lapaʻau akamai a me nā mea noiʻi, hāʻawi mākou i ka mālama kiʻekiʻe a me ke kākoʻo ma o ke kaʻina hana lapaʻau.

Ke ʻAno Holoʻokoʻa: Hāʻawi mākou i ka mālama piha, mai ka loiloi ʻana i ka mea maʻi a hiki i ka hoʻokele ʻana i ka lāʻau lapaʻau a me ka hahai ʻana, e hōʻoiaʻiʻo ana i nā hopena kūpono loa.